Suspension of trading

Quotes Deciphera Pharmaceuticals, Inc.

Stocks

Delayed Nasdaq 16:00:00 2024-06-10 EDT			5-day change	1st Jan Change
25.59 ^USD	+0.08%		-.--%	-

06-17	Deciphera Pharmaceuticals, LLC Doses First Patient In Pivotal Phase 3 INTREPID Study Of Sapablursen In Polycythemia Vera	CI
03-26	Ono Pharmaceutical Co., Ltd. Submits Application for Approval of Ripretinib in Japan	CI

Stock exchange

Nasdaq DCPH 25.59 $ +0.08% 40.84M $

markets

Capital turnover ratio

Float rotation

Market Cap (USD)

2,212,920,123

Net sales ()

163

Number of employees

355

Sales / Employee ()

Sales / Employee (USD)

Free-Float

71.62 %

Free-Float capitalization (USD)

1,584,999,638

Moving average 5 days

25.57

Moving average 100 days

18.38

Price spread / (MMA5)

-0.07%

Price spread / (MMA100)

-28.17%

STIM

RSI 9 days

RSI 14 days

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DECIPHERA PHARMACEUTICALS, INC.	+0.08%	-.--%	-.--%	+76.00%	2.21B
WUXI APPTEC CO., LTD.	+0.41%	-2.07%	+41.26%	+95.40%	69.02B
ARGENX SE	-0.90%	+1.07%	+43.30%	+90.52%	66.32B
INSMED INCORPORATED	+0.04%	+4.36%	-11.72%	+459.54%	27.66B
BIONTECH SE	-0.90%	-7.65%	+2.45%	-15.50%	25.84B
WUXI BIOLOGICS (CAYMAN) INC.	-3.00%	-2.90%	+39.40%	+9.41%	26.54B
GENMAB A/S	-0.20%	+1.67%	+25.62%	-17.69%	20.4B
PHARMAESSENTIA CORPORATION	+3.45%	-13.46%	+222.69%	+389.50%	17.63B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-1.49%	-4.88%	-0.41%	+530.26%	15.15B
EXELIXIS, INC.	+1.03%	+7.00%	+59.98%	+160.03%	14.65B
Average	-0.14%	-1.24%	+42.26%	+177.75%	28.54B
Weighted average by Cap.	-0.28%	-0.83%	+41.43%	+147.85%